Clonogenic inactivation of colon cancer-derived cells treated with 5- fluorouracil and indomethacin in hybrid spheroids

Acta Oncologica

Volumn 37, Issue 7-8, 1998, Pages 735-739

  Djordjevic, Bozidar ^a,b   Lange, Christopher S ^a   Schwartz, Michael S ^a   Rotman, Marvin ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; INDOMETACIN;

ARTICLE; CANCER CELL CULTURE; CELL CONTACT; CELL CYCLE G1 PHASE; CELL SURVIVAL; CLONOGENIC ASSAY; COLON CANCER; COLONY FORMATION; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG EFFECT; HUMAN; HUMAN CELL; HYBRID CELL; PRIORITY JOURNAL; SPHEROID CELL;

ADENOCARCINOMA; ANTIMETABOLITES, ANTINEOPLASTIC; CELL SURVIVAL; COLONIC NEOPLASMS; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROURACIL; HELA CELLS; HUMANS; INDOMETHACIN; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 0032411499     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418698430124     Document Type: Article

References (17)

1. 1. Hahn GM, Ray GR, Gordon LF, Kallman RF. Response of solid tumor cells exposed to chemotherapeutic agents in vivo: Cell survival after 2- and 24-hour exposure. J Natl Cancer Inst 1973; 50: 529-33.
2. 2. Nakajima Y, Miyamoto T, Tanabe M, Watanabe I, Terasima T. Enhancement of mammalian cell killing by 5-fluorouracil in combination with x-rays. Cancer Res 1979; 39: 3763-7.
3. 3. Fairchild CR, Cowan KH. Keynote address: multidrug resistance: a pleiotropic response to cytotoxic drugs. Int J Radiat Oncol Biol Phys 1991; 20: 361-7.
4. 4. Tannock IF. Toxicity of 5-fluorouracil for aerobic and hypoxic cells in two murine tumors. Cancer Chemother Pharmacol 1987; 19: 53-6.
5. 5. Durand RE. Chemosensitivity testing in V79 spheroids: drug delivery and cellular microenvironment. J Natl Cancer Inst 1986; 77: 247-52.
6. 6. Sutherland RM. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 1988; 240: 177-84.
7. 7. Carlsson J, Nederman T. Tumor spheroid technology in cancer therapy research. Eur J Cancer 1989; 25: 1127-33.
8. 8. Rofstad EK. Growth and radiosensitivity of malignant melanoma spheroids initiated directly from surgical specimens of tumors in man. Br J Cancer 1986; 54: 569-78.
9. 9. Lange CS, Djordjevic B, Brock WA. The hybrid spheroid clonogenic assay for the intrinsic radio- and chemo-sensitivities of human tumors. Int J Radiat Oncol Biol Phys 1992; 24: 511-7.
10. 10. Djordjevic B, Lange CS, Allison RR, Rotman M. Response of primary colon cancer cells in hybrid spheroids to 5-fluorouracil. Cancer Investigation 1993; 11: 291-8.
11. 11. Gregoire V, Hunter NR, Brock WA, Hittelman WN, Plunkett W, Milas L. Improvement in the therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus fludarabine. Radiat Res 1996; 146: 548-53.
12. 12. Lawrence TS, Davies MA, Tang HY, Maybaum J. Fluorodeoxyuridine-mediated cytotoxicity and radiosensitization require S phase progression. Int J Radiat Biol 1996; 70: 273-80.
13. 1 phase of the cell cycle by indomethacin. J Pharmacol Exp Ther 1979; 210: 106-11.
14. 14. Grandi M, Geroni C, Giuliani FC. Isolation and characterization of a human colon carcinoma cell line resistant to doxorubicin. Br J Cancer 1986; 54: 515-8.
15. 15. Fertil B, Dertinger H, Courdi A, Malaise EP. Mean inactivation dose: a useful concept for intercomparison of human cell survival curves. Radiat Res 1984; 99: 73-84.
16. 16. Matsuoka H, Hiroaki U, Sugimachi K, Akiyoshi T. Preliminary evidence that incorporation of 5-fluorouracil into RNA correlates with antitumor response. Cancer Investigation 1992; 10: 265-9.
17. 17. O'Reilly M, Gamelli RL. Indomethacin augments granulocyte-macrophage colony stimulating factor-induced hematopoiesis following 5-FU treatment. Exp Hematol 1990; 18: 974-8.